Results 81 to 90 of about 17,529 (206)

Teicoplanin allergy - an emerging problem in the anaesthetic allergy clinic

, 2015
Background Anaphylaxis to teicoplanin appears to be extremely rare, with only one confirmed case report worldwide. Two anaesthetic allergy clinics in the UK have received a number of suspected cases referred for investigation, and we present here the ...
Savic, S, Harper, NJN, Savic, LC, Hopkins, PM, Garcez, T   +4 more
core   +1 more source

Specificity of Induction of Glycopeptide Antibiotic Resistance in the Producing Actinomycetes

Antibiotics, 2018
Glycopeptide antibiotics are drugs of last resort for treating severe infections caused by Gram-positive pathogens. It is widely believed that glycopeptide-resistance determinants (van genes) are ultimately derived from the producing actinomycetes.
Elisa Binda, Pamela Cappelletti, Flavia Marinelli, Giorgia Letizia Marcone   +3 more
doaj   +1 more source

Improved production of teicoplanin using adsorbent resin in fermentations

, 2003
Aims: To use adsorbent resins in fermentations to eliminate toxic effects on growth, reduce feedback repression of production and assist in recovery of teicoplanin. Methods and Results: An adsorbent resin was added to the culture broth for the adsorption
Jae-Chan Lee, Hae Ryong Park, Dong Jin park, Chang-Jin Kim, Hyang Burm Lee, Y B Kim   +5 more
core   +1 more source

Beyond One-Size-Fits-All: Tailoring Teicoplanin Regimens for Normal Renal Function Patients Using Population Pharmacokinetics and Monte Carlo Simulation

Pharmaceutics
In patients with normal renal function, significant teicoplanin dose adjustments are often necessary. This study aimed to develop a population pharmacokinetic (PK) model for teicoplanin in healthy adults and use it to recommend optimal dosage regimens ...
Yong-Kyun Kim, Kyeong-Min Jo, Jae-Ha Lee, Ji-Hoon Jang, Eun-Jun Choe, Gaeun Kang, Dae-Young Zang, Dong-Hwan Lee   +7 more
doaj   +1 more source

Diffusion of teicoplanin and vancomycin in agar

, 1992
Teicoplanin, although more active than vancomycin [by minimum inhibitory concentration (MIC)], produces smaller inhibition zones in sensitivity testing with 30-μg disks.
F. Parenti, A. Danese, L. A. Cavenaghi, E. Biganzoli   +3 more
core   +1 more source

Machine learning-based prediction model for teicoplanin plasma concentrations in adults with liver disease using real-world data

Frontiers in Pharmacology
ObjectiveTo construct a prediction model for teicoplanin (TEIC) plasma concentrations through machine learning and deep learning techniques in patients with liver disease using real-world clinical data.MethodsA retrospective study was conducted on ...
Fengbi Jian, Xiaodong Chen, Ming Wang, Zhihao Guo, Xuechun Li, Haobin Jian, Ronghong Ji, Liying Liang, Ze Yu, Yanfang Chen   +9 more
doaj   +1 more source

Total Synthesis of the Teicoplanin Aglycon

, 2016
Total Synthesis of the Teicoplanin ...
Dale L. Boger (1306542), Harald Strittmatter (2982075), Yoshiki Mori (2720617), Susumu Miyazaki (702636), Jian-Hui Weng (2982078), Steven L. Castle (1676884), J. Jeffrey McAtee (2982081), Seong Heon Kim (713448), Olivier Rogel (2093572)   +8 more
core   +1 more source

Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study

, 2012
[[abstract]]Objectives Higher vancomycin MIC values (≥1.5 mg/L via Etest) may be associated with vancomycin treatment failure among patients with serious methicillin-resistant Staphylococcus aureus (MRSA) infections.
Chang, HJ;Hsu, PC;Yang, CC;Siu, LK;Kuo, AJ;Chia, JH;Wu, TL;Huang, CT;Lee, MH
core   +1 more source

Pharmacodynamics of teicoplanin against MRSA

, 2017
Objectives: The overall study aim was to identify the relevant preclinical teicoplanin pharmacokinetic (PK)/pharmacodynamic (PD) indices to predict efficacy and suppression of resistance in MRSA infection.
Farrington N., McEntee L., Ramos-Martin V., Cojutti P., Pea F., Padmore K., Hope W. W., Johnson A., Neely M. N.   +8 more
core   +2 more sources

Process for Transforming Teicoplanin Factor A2 Component 1 into Teicoplanin Factor A2 Component 3

, 1985
The present invention refers to a process for transforming teicoplanin factor A2 component 1 into teicoplanin factor A2 component 3 by means of a chemical reaction which includes the catalytical hydrogenation of the ...
Cavalleri B., STRAZZOLINI, Paolo
core